Scientist.com, the online marketplace for outsourced research, announced today that Coronadan Chris Petersen, its Chief Technology Officer (CTO) and Founder, has been awarded the Cox Business Exemplary Award as part of San Diego’s 2019 “Top Tech Awards”. Presented by Cox Business, the Top Tech Awards celebrate excellence among the San Diego business community’s technology executives. Petersen was selected for this special award by his peers from a field of over 400 highly-qualified applicants.
“Because it saves time and money and promotes innovation, the Scientist.com marketplace Chris built has the potential to solve the most challenging problem facing the pharmaceutical industry today - how to create more drugs while spending less money,” said Kevin Lustig, PhD, Scientist.com CEO and Founder. “Chris’ outstanding work and perseverance have gone a long way toward realizing the company’s mission to help cure all human diseases by 2050.”
As a 2014 Top Tech Award honoree and judge (up until 2018), Petersen is an expert in developing online solutions to complex scientific processes. Under his leadership, Scientist.com has grown from a small start-up into one of America’s fastest-growing and most innovative private companies. In August 2018, Scientist.com ranked #9 on Inc. magazine’s annual list of the 5000 fastest growing private companies in the US and #2 on the San Diego Business Journal’s annual list of fast-growing local companies. In 2018, the company also ranked #12 on Entrepreneur magazine’s E360 list of America’s Best Companies. Petersen has personally written the software code underlying much of the Scientist.com marketplace, and he oversees all aspects of data privacy, data security and data integrity of the company’s entire IT platform.
“I am so thankful for the opportunity to pursue a career I love while making a difference in people’s lives,” said Petersen, Scientist.com CTO and Founder. “At Scientist.com, we believe technology will be the most disruptive and innovative driving force behind medical research in the coming decades.”